Abstract:The SW13 human adrenocortical carcinoma line is a uniquely powerful model in which to probe the relationship between progranulin processing and cellular activity as it exists in two epigenetically distinct subtypes. The SW13- subtype has an epithelial morphology and is highly proliferative, while the SW13+ subtype has a mesenchymal-like phenotype and a higher metastatic potential. These two subtypes both express progranulin and interconvert by epigenetic mechanisms, as treatment of SW13- cells with histone deacetylase inhibitors (HDACi) adopt a SW13+ phenotype. Progranulin is composed of 71⁄2 highly conserved granulin repeats which are subject to proteolytic processing and may serve as a prognostic biomarker in cancer as progranulin units regulate varied cellular activities including proliferation, migration, inflammation, and lysosomal function. Thus, biological activity of progranulin is dependent on the cellular proteases expressed. Indicative of differential processing, treatment of SW13- cells with exogenous progranulin results in an increase in growth rate, while no effect on SW13+ cell growth was observed. As the SW13+ subtype expresses a higher amount of progranulin than the SW13- subtype, these data are consistent with an inability of SW13+ to process endogenous progranulin to mitogenic granulin unit(s). Immunoblotting with granulin-specific antibodies indicates that progranulin may be processed differently in each subtype. In this work, we focused on lysosomes as a potential site for differential processing of progranulin for two reasons. First, lysosomal proteases have been shown to process progranulin and progranulin itself plays a role in lysosome maturation. Second, differences in lysosomal pH between the two subtypes have been detected using two pH-sensitive dyes which localize to the lysosome. Interestingly, proteomic analysis of lysosomes isolated from each subtype confirms lysosomal dysfunction and suggests upregulation of inflammatory proteins in SW13+ cells. Both proteomics and lipidomics suggest alterations in lipid metabolism. Ongoing experiments will address whether restoration of lysosomal function impacts progranulin production and/or processing in SW13 subtypes. Citation Format: Kathryn J. Leyva, Andrew Z. Yang, Pegah Biparva, Chika Okonya, Chandana K. Uppalapati, Alisha M. Harrison, Agnes S. Pascual, Elizabeth E. Hull. Elucidating a mechanistic link between progranulin and lysosomal function in SW13 cells: Implications for inflammation and lipid metabolism [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 2 (Late-Breaking, Clinical Trial, and Invited s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(7_Suppl) nr LB189.

Granulins rescue inflammation, lysosome dysfunction, lipofuscin, and neuropathology in a mouse model of progranulin deficiency

Early lysosomal maturation deficits in microglia triggers enhanced lysosomal activity in other brain cells of progranulin knockout mice

Progranulin Protects Against Amyloid Β Deposition and Toxicity in Alzheimer’s Disease Mouse Models

Pathogenic cysteine mutations affect progranulin function and production of mature granulins.

Progranulin loss results in sex-dependent dysregulation of the peripheral and central immune system

Methods to Investigate the Molecular Basis of Progranulin Actions on Brain and Behavior In Vivo Using Knockout Mice

Delivering progranulin to neuronal lysosomes protects against excitotoxicity

Analysis of the Biomarkers for Neurodegenerative Diseases in Aged Progranulin Deficient Mice

Progranulin as a therapeutic target in neurodegenerative diseases

Lysosomal functions of progranulin and implications for treatment of frontotemporal dementia

Investigating the Role and Regulation of GPNMB in Progranulin-deficient Macrophages

Abstract LB189: Elucidating a mechanistic link between progranulin and lysosomal function in SW13 cells: Implications for inflammation and lipid metabolism

Targeting progranulin alleviated silica particles-induced pulmonary inflammation and fibrosis via decreasing Il-6 and Tgf-β1/Smad

Progranulin deficiency attenuates tubulointerstitial injury in a mouse unilateral ureteral obstruction model

Progranulin from different gliocytes in the nucleus accumbens exerts distinct roles in FTD- and neuroinflammation-induced depression-like behaviors

Losing protein in the brain: the case of progranulin

Discovery of small molecules that normalize the transcriptome and enhance cysteine cathepsin activity in progranulin-deficient microglia

Dendritic spine head diameter is reduced in the prefrontal cortex of progranulin haploinsufficient mice

Loss of synaptic zinc transport in progranulin deficient mice may contribute to progranulin-associated psychopathology and chronic pain

ASO-mediated knockdown of GPNMB in mutant-GRN and Grn-deficient peripheral myeloid cells disrupts lysosomal function and immune responses

Progranulin: A promising biomarker and therapeutic target for fibrotic diseases